Picture of Irras AB logo

IRRAS Irras AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: IRRAS Announces Release Of Clinical Data Regarding IRRAflow

Sept 29 (Reuters) - Irras AB  IRRAS.ST :
    * IRRAS ANNOUNCES RELEASE OF CLINICAL DATA THAT VALIDATES
SAFETY
AND EFFECTIVENESS OF IRRAFLOW SYSTEM IN TREATING CHRONIC
SUBDURAL HEMATOMAS
    * NO COMPLICATIONS OR RECURRENCE OF BLEEDING SEEN DURING
PATIENT
TREATMENTS AT UNIVERSITY OF CALIFORNIA IRVINE
    * RESEARCH SHOWED IRRAFLOW SAFELY TREATS SUBDURAL HEMATOMAS
WHILE
DECREASING COMPLICATIONS, BLEEDING RECURRENCE, AND LENGTH OF
HOSPITALIZATION

Source text for Eikon:  ID:nWkr2XkGPh 
Further company coverage:  IRRAS.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))

Recent news on Irras AB

See all news